Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 887212

Pharmacogenetics of antidepressant response : A polygenic approach

García-González, J.; Tansey, K.E.; Hauser, J.; Henigsberg, Neven; Maier, W.; Mors, O.; Placentino, A.; Rietschel, M.; Souery, D.; Žagar, T. et al.
Pharmacogenetics of antidepressant response : A polygenic approach // Progress in neuro-psychopharmacology & biological psychiatry, 75 (2017), 128-134 doi:10.1016/j.pnpbp.2017.01.011 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 887212 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pharmacogenetics of antidepressant response : A polygenic approach

Autori
García-González, J. ; Tansey, K.E. ; Hauser, J. ; Henigsberg, Neven ; Maier, W. ; Mors, O. ; Placentino, A. ; Rietschel, M. ; Souery, D. ; Žagar, T. ; Czerski, P.M. ; Jerman, B. ; Buttenschøn, H.N. ; Schulze, T.G. ; Zobel, A. ; Farmer, A. ; Aitchison, K.J. ; Craig, I. ; McGuffin, P. ; Giupponi, M. ; Perroud, N. ; Bondolfi, G. ; Evans, D. ; O'Donovan, M. ; Peters, T.J. ; Wendland, J.R. ; Lewis, G. ; Kapur, S. ; Perlis, R. ; Arolt, V. ; Domschke, K. ; Major Depressive Disorder Working Group of the Psychiatric Genomic Consortium ; Breen, G ; Curtis, C ; Sang-Hyuk, L ; Kan, C ; Newhouse, S ; Patel, H ; Baune, BT ; Uher, R ; Lewis, CM ; Fabbri, C

Izvornik
Progress in neuro-psychopharmacology & biological psychiatry (0278-5846) 75 (2017); 128-134

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Antidepressant ; Major depressive disorder ; Pharmacogenomics ; Polygenic risk scores ; Schizophrenia

Sažetak
Major depressive disorder (MDD) has a high personal and socio-economic burden and >60% of patients fail to achieve remission with the first antidepressant. The biological mechanisms behind antidepressant response are only partially known but genetic factors play a relevant role. A combined predictor across genetic variants may be useful to investigate this complex trait. Polygenic risk scores (PRS) were used to estimate multi-allelic contribution to: 1) antidepressant efficacy ; 2) its overlap with MDD and schizophrenia. We constructed PRS and tested whether these predicted symptom improvement or remission from the GENDEP study (n=736) to the STAR*D study (n=1409) and vice-versa, including the whole sample or only patients treated with escitalopram or citalopram. Using summary statistics from Psychiatric Genomics Consortium for MDD and schizophrenia, we tested whether PRS from these disorders predicted symptom improvement in GENDEP, STAR*D, and five further studies (n=3756). No significant prediction of antidepressant efficacy was obtained from PRS in GENDEP/STAR*D but this analysis might have been underpowered. There was no evidence of overlap in the genetics of antidepressant response with either MDD or schizophrenia, either in individual studies or a meta-analysis. Stratifying by antidepressant did not alter the results. We identified no significant predictive effect using PRS between pharmacogenetic studies. The genetic liability to MDD or schizophrenia did not predict response to antidepressants, suggesting differences between the genetic component of depression and treatment response. Larger or more homogeneous studies will be necessary to obtain a polygenic predictor of antidepressant response.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Marija-Biserka Jerman (autor)

Avatar Url Neven Henigsberg (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com doi.org

Citiraj ovu publikaciju:

García-González, J.; Tansey, K.E.; Hauser, J.; Henigsberg, Neven; Maier, W.; Mors, O.; Placentino, A.; Rietschel, M.; Souery, D.; Žagar, T. et al.
Pharmacogenetics of antidepressant response : A polygenic approach // Progress in neuro-psychopharmacology & biological psychiatry, 75 (2017), 128-134 doi:10.1016/j.pnpbp.2017.01.011 (međunarodna recenzija, članak, znanstveni)
García-González, J., Tansey, K., Hauser, J., Henigsberg, N., Maier, W., Mors, O., Placentino, A., Rietschel, M., Souery, D. & Žagar, T. (2017) Pharmacogenetics of antidepressant response : A polygenic approach. Progress in neuro-psychopharmacology & biological psychiatry, 75, 128-134 doi:10.1016/j.pnpbp.2017.01.011.
@article{article, author = {Garc\'{\i}a-Gonz\'{a}lez, J. and Tansey, K.E. and Hauser, J. and Henigsberg, Neven and Maier, W. and Mors, O. and Placentino, A. and Rietschel, M. and Souery, D. and \v{Z}agar, T. and Czerski, P.M. and Jerman, B. and Buttensch\on, H.N. and Schulze, T.G. and Zobel, A. and Farmer, A. and Aitchison, K.J. and Craig, I. and McGuffin, P. and Giupponi, M. and Perroud, N. and Bondolfi, G. and Evans, D. and O'Donovan, M. and Peters, T.J. and Wendland, J.R. and Lewis, G. and Kapur, S. and Perlis, R. and Arolt, V. and Domschke, K. and Breen, G and Curtis, C and Sang-Hyuk, L and Kan, C and Newhouse, S and Patel, H and Baune, BT and Uher, R and Lewis, CM and Fabbri, C}, year = {2017}, pages = {128-134}, DOI = {10.1016/j.pnpbp.2017.01.011}, keywords = {Antidepressant, Major depressive disorder, Pharmacogenomics, Polygenic risk scores, Schizophrenia}, journal = {Progress in neuro-psychopharmacology and biological psychiatry}, doi = {10.1016/j.pnpbp.2017.01.011}, volume = {75}, issn = {0278-5846}, title = {Pharmacogenetics of antidepressant response : A polygenic approach}, keyword = {Antidepressant, Major depressive disorder, Pharmacogenomics, Polygenic risk scores, Schizophrenia} }
@article{article, author = {Garc\'{\i}a-Gonz\'{a}lez, J. and Tansey, K.E. and Hauser, J. and Henigsberg, Neven and Maier, W. and Mors, O. and Placentino, A. and Rietschel, M. and Souery, D. and \v{Z}agar, T. and Czerski, P.M. and Jerman, B. and Buttensch\on, H.N. and Schulze, T.G. and Zobel, A. and Farmer, A. and Aitchison, K.J. and Craig, I. and McGuffin, P. and Giupponi, M. and Perroud, N. and Bondolfi, G. and Evans, D. and O'Donovan, M. and Peters, T.J. and Wendland, J.R. and Lewis, G. and Kapur, S. and Perlis, R. and Arolt, V. and Domschke, K. and Breen, G and Curtis, C and Sang-Hyuk, L and Kan, C and Newhouse, S and Patel, H and Baune, BT and Uher, R and Lewis, CM and Fabbri, C}, year = {2017}, pages = {128-134}, DOI = {10.1016/j.pnpbp.2017.01.011}, keywords = {Antidepressant, Major depressive disorder, Pharmacogenomics, Polygenic risk scores, Schizophrenia}, journal = {Progress in neuro-psychopharmacology and biological psychiatry}, doi = {10.1016/j.pnpbp.2017.01.011}, volume = {75}, issn = {0278-5846}, title = {Pharmacogenetics of antidepressant response : A polygenic approach}, keyword = {Antidepressant, Major depressive disorder, Pharmacogenomics, Polygenic risk scores, Schizophrenia} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.